Legs up the wall
What studies of legs up the wall found
At a glance, by condition
ME/CFS: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty): 4 of 5 findings are C.
5 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Legs up the wall might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Legs up the wall · ME/CFS is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
ME/CFS
Symptoms
Autonomic symptoms1 study · 1 (few people) person took part in legs up the wall Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · 11 week intervention · 10 to 15 minutes up to five times daily (few people)
Autonomic symptoms improved.
The evidence is very uncertain about the effect of legs up the wall on autonomic symptoms in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026) preprint
- People in the study
- 1 in the study
- Dose
- 10 to 15 minutes up to five times daily
- Outcome
- Baseline HRV (RMSSD in ms) root mean square of successive differences (RMSSD)
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Sleep1 study · 1 (few people) person took part in legs up the wall Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · 11 week intervention · 10 to 15 minutes up to five times daily (few people)
Sleep improved.
The evidence is very uncertain about the effect of legs up the wall on sleep in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026) preprint
- People in the study
- 1 in the study
- Dose
- 10 to 15 minutes up to five times daily
- Outcome
- Sleep Quality Score
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Low mood or anxiety1 study · 1 (few people) person took part in legs up the wall Little or no difference D
Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all).
Studies with no comparison group1 in the study · 11 week intervention · 10 to 15 minutes up to five times daily (few people)
No clear change in low mood or anxiety.
The evidence is very uncertain about the effect of legs up the wall on low mood or anxiety in ME/CFS. Little or no difference · very low certainty D
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
See the 1 study
-
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026) preprint
- People in the study
- 1 in the study
- Dose
- 10 to 15 minutes up to five times daily
- Outcome
- I don't feel stressed. Firstbeat Wellbeing survey
- Effect
- no clear difference
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Daily life and health overall
Daily functioning1 study · 1 (few people) person took part in legs up the wall Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · 11 week intervention · 10 to 15 minutes up to five times daily (few people)
Daily functioning improved.
The evidence is very uncertain about the effect of legs up the wall on daily functioning in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026) preprint
- People in the study
- 1 in the study
- Dose
- 10 to 15 minutes up to five times daily
- Outcome
- Pacing and functional capacity for ADLs
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 1 (few people) person took part in legs up the wall Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · 11 week intervention · 10 to 15 minutes up to five times daily (few people)
Overall symptoms improved.
The evidence is very uncertain about the effect of legs up the wall on overall symptoms in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026) preprint
- People in the study
- 1 in the study
- Dose
- 10 to 15 minutes up to five times daily
- Outcome
- Subjective Wellbeing Firstbeat Wellbeing survey
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Side effects
Stopping because of side effects1 study
A 10-day trial of low dose naltrexone resulted in a sharp drop in overall HRV and a near-total absence of nocturnal PNS recovery, which was resolved upon discontinuation
Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management (2026)
Side effects studies reported2 kinds
| Side effect | Studies that reported it |
|---|---|
| Trouble sleeping | 1 study |
| Worse symptoms or a flare | 1 study |
All papers
- Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management2026 · case report · 1 in the study · preprint
Summary
This case report describes one patient with ME/CFS for relapse management in standard client sessions who used continuous heart rate variability (C-HRV) biofeedback with an ECG-grade Firstbeat Life device, health coaching and HRV specialist interpretation for an 11-week intervention, alongside pacing, sleep optimisation, task modification and autonomic regulation strategies. There was no comparison group. The paper reports within-patient changes from baseline to 11 weeks: baseline HRV (RMSSD) rose from 24 ms to 33 ms (+37.5%); Sleep Quality Score from 37/100 to 56/100 (+51.4%); Stress and Recovery Balance Score from 23/100 to 48/100 (+108.7%); and Subjective Wellbeing from 24% to 34% (+41.7%). On the Firstbeat Wellbeing survey, 'I feel that I sleep enough' was 40% at Week 1 and 80% at Week 11 (difference 40); 'I don't feel stressed' was 80% and 80% (0); 'My days include breaks and time for recovery' 80% and 100% (20); 'I feel alert and energetic most of the time' 20% and 40% (40); 'I feel well at the moment' 20% and 40% (60). Harms reported included a sharp drop in overall HRV and near-total absence of nocturnal PNS recovery during a 10-day low dose naltrexone trial, and a complete lack of PNS recovery during sleep on three separate palmitoylethanolamide trials; a severe immune flare occurred immediately after the 11-week intervention. Withdrawals for harms were not reported. The authors state the findings are from a single case (N=1) and may not be representative.